Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Sunshine Lake Pharma Co: Clinical Trials & FDA Approval Profile

Sunshine Lake Pharma Co (Global / Institutional) sponsors 18 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 8 active protocols (6 recruiting now), 6 completed protocols, and 1 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)22.2%
Median Closed Enrollment vs National (145 pts)68 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Sunshine Lake Pharma Co
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)18
Active Pipeline (Recruiting Now)8 (6)
Completed vs Stopped Early6 / 4 (22.2%)
Median Closed Actual Enrollment68 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals1 (1 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Sunshine Lake Pharma Co
Hospital Research SiteLocationShared Protocols
The First Hospital of Jilin UniversityChangchun, Jilin4
Peking University People's HospitalBeijing, Beijing Municipality4
Nanfang Hospital of Southern Medical UniversityGuangzhou, Guangdong4

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Sunshine Lake Pharma Co
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT04147208Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV InfectionPhase IICOMPLETED
NCT03487107Phase 3 Study of Yimitasvir Phosphate CapsulesPhase IIICOMPLETED
NCT05395416Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis CPhase II/IIICOMPLETED

Explore interactive annual charts and M&A subsidiary rollups in the Sunshine Lake Pharma Co Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI